Biodexa Pharmaceuticals (BDRX) Restructuring Costs (2014 - 2015)
Biodexa Pharmaceuticals' Restructuring Costs was $3.87 million in the quarter ended Dec 31, 2015, compared with $272,517 a year earlier.
Powered by 
Analysis
Biodexa Pharmaceuticals (BDRX) Restructuring Costs (2014 - 2015) Analysis & Trends
For the year ended Dec 31, 2015, Restructuring Costs at Biodexa Pharmaceuticals came in at -$1.03 million.
- In earlier years, Restructuring Costs was $283,456 in the year ended Dec 31, 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Biodexa Pharmaceuticals | 41.06 Mn | 17.85 Mn | - |
API Access
Biodexa Pharmaceuticals Restructuring Costs API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=restructuring-costs&ticker=BDRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "restructuring-costs", "ticker": "BDRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=restructuring-costs&ticker=BDRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();